Pharmacologic transglutaminase inhibition attenuates drug-primed liver hypertrophy but not Mallory body formation

This publication has 31 references indexed in Scilit:

• Keratin 8 overexpression promotes mouse Mallory body formation
  The Journal of cell biology, 2005
• Intermediate Filament Proteins and Their Associated Diseases
  New England Journal of Medicine, 2004
• The keratin cytoskeleton in liver diseases
  The Journal of Pathology, 2004
• Tissue transglutaminase-induced aggregation of α-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies
  Proceedings of the National Academy of Sciences, 2003
• Transglutaminases: crosslinking enzymes with pleiotropic functions
  Nature Reviews Molecular Cell Biology, 2003
• Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine
  Nature Medicine, 2002
• Keratins: Guardians of the liver
  Hepatology, 2002
• Cytokeratin 8 Protects from Hepatotoxicity, and Its Ratio to Cytokeratin 18 Determines the Ability of Hepatocytes to Form Mallory Bodies
  The American Journal of Pathology, 2000
• Alterations of intermediate filaments in various histopathological conditions
  Biochemistry and Cell Biology, 1995
• Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.
  Proceedings of the National Academy of Sciences, 1982